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The aromatic rhizomes of Acorus calamus L. are used
extensively in traditional medicine worldwide. They
reportedly relieve stomach cramps, dysentery and asth-
ma, and are used as anthelmintics, insecticides, tonics
and stimulants. Alcoholic rhizome extracts of A. cala-
mus growing in KwaZulu-Natal, South Africa, were pre-
viously found to have anthelmintic and antibacterial
activity. Using bioassay-guided fractionation, the
phenylpropanoid β-asarone was isolated from the rhi-
zome. This compound was shown to possess
anthelmintic and antibacterial activity. It has previously
been isolated from A. calamus, and a related species, A.
gramineus. Different varieties of A. calamus exhibit dif-
ferent levels of β-asarone, with the diploid variety con-
taining none of the compound. Mammalian toxicity and
carcinogenicity of asarones has been demonstrated by
other researchers, supporting the discouragement of
the medicinal use of Acorus calamus by traditional heal-
ers in South Africa.
Over the last few hundred years, many introduced plants
have been incorporated into traditional medicine in southern
Africa. One such example is the now extensive use of
Acorus calamus, or calamus as it is known. Acorus calamus,
of the family Araceae, is a reed-like, semi-aquatic, perennial
plant with a stout aromatic rhizome. The inconspicuous flow-
ers are compactly arranged on a long, fleshy axis, sur-
rounded by a large leaf-like spathe. All parts of the plant
have a pungent, not unattractive smell. It is indigenous to
South East Asia, but is now widely distributed in Europe,
eastern North America and parts of Africa (Van Wyk et al.
1997). It has been cultivated in South Africa for many years
and has become a popular component of Zulu medicine.
The plant is used extensively in traditional medicine world-
wide. Rhizomes have been used as carminatives, stom-
achics and to treat dysentery in southern Africa, Europe and
Asia (Watt and Breyer-Brandwijk 1962). They are used as
tonics, stimulants and aphrodisiacs, and to treat rheuma-
tism, toothache and respiratory ailments (Hutchings et al.
1996). In the Cape, the use of the rhizome as a carminative
and diarrhoea remedy has been recorded (Watt and Breyer-
Brandwijk 1962). In India, the powdered rootstock and rhi-
zome are used as an antispasmodic, anthelmintic and insec-
ticide (Watt and Breyer-Brandwijk 1962). The fragrant oils
obtained from the rhizome are also used as flavourants in
alcoholic beverages and as fragrant essences in perfumes
and sacred oils (Motley 1994).
Essential oils are found in the leaves, rhizomes and roots,
tannins occur in the rhizome and roots, and ascorbic acid is
found in the leaves and rhizomes (Pamakstyte-Jukneviciene
1971, cited by Hutchings et al. 1996). Owing to its previous
wide usage as a crude drug, much research has been
undertaken on the constituents of the oil. The major chemi-
cal constituents of the essential oils are phenylpropanes,
monoterpenes and thermolabile sesquiterpenoids (Röst and
Bos 1979, cited by Motley 1994). Methyleugenol, cis-
methylisoeugenol, β-asarone, geranylacetate, β-farnesene,
shyobunone, epishyobunone and isoshyobunone are the
most abundant chemical compounds, constituting about
20% of the essential oil (Röst and Bos 1979, cited by Motley
1994). Other chemical components include α-asarone, γ-
asarone, calamenene, asaronaldehyde, acorenone, cala-
menone, n-heptanic acid, calamendiol, many sesquiter-
penes, and trace amounts of other compounds (Mazza
1985). The proportion of each chemical constituent of the oil,
particularly in the case of β-asarone, varies between the
varieties of A. calamus, corresponding to the ploidy (Röst
and Bos 1979, cited by Schmidt and Streloke 1994). The
diploid caryotype grows in North America and in parts of Asia
(Siberia), and the rhizomes contain little or no β-asarone
(Röst and Bos 1979, cited by Schmidt and Streloke 1994). In
the triploid caryotype, present in central Europe and
Kashmir, the β-asarone content of the rhizomes varies from
9–13%, while in the tetraploid caryotype, found in India, east
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Asia and Japan, the essential oil of the rhizomes is 70–96%
β-asarone (Röst and Bos 1979, cited by Schmidt and
Streloke 1994). The ploidy of African plants has not to our
knowledge been investigated.
The compound β-asarone is known to be toxic (Abel 1987,
Lander and Schreier 1990), and there is evidence that it may
induce duodenal and liver cancer in rats (Haberman 1971,
cited by Göggelman and Schimmer 1983). As a result, many
countries have discontinued the use of Acorus in digestive
medicines. Calamus has been banned by the FDA as a food
additive and within the last few years many herbal shops
have stopped recommending or dispensing it. Although cala-
mus and its products are banned in the United States, they
are authorised in Europe, where the highest acceptable con-
centration in foods and beverages is 0.1mg kg-1 and in alco-
holic beverages, 1mg kg-1 (Lander and Schreier 1990).
Much work has been done on investigating the biological
activity of Acorus calamus, particularly in India and Europe.
Extracts from the plant show larvicidal activity (Chavan et al.
1976, cited by Hutchings et al. 1996). The antigonadal activ-
ity of β-asarone is potentially useful in insect control (Saxena
et al. 1977). The ethanolic extract has shown anti-secreta-
gogue, anti-ulcer and cytoprotective properties in rats
(Rafatullah et al. 1994), supporting the use of calamus for
the treatment of gastric ailments in traditional medicine.
Rhizomes and roots have sedative, hypotensive, analgesic
and hallucinogenic effects (Agarwal et al. 1956, Sharma and
Dandiya 1969). The active hallucinogenic principles are pre-
sumed to be α-asarone (chemically similar to mescaline, a
psychoactive alkaloid) and the cis-isomer β-asarone (chem-
ically similar to myristicin and kava alkaloids) (Lewis and
Elvin-Lewis 1977).
Fungicidal effects of A. calamus have been reported
(Alankararao and Rajendra Prasad 1981, Vashi and Patel
1987, Saxena et al. 1990, Jatisatienr and Jatisienr 1999). An
anti-mycotic principle was identified as β-asarone, with α-
asarone displaying a similar level of activity (Ohmoto and
Sung 1982). The essential oil and alcoholic extracts of the
rhizomes have been shown to have antibacterial activity
against many Gram-positive and Gram-negative bacteria
(Kar and Jain 1971, Alankararao and Rajendra Prasad
1981, Vashi and Patel 1987). The compounds responsible
for the antibacterial activity have not to our knowledge been
investigated.
The dried rhizome gave positive results as an antiamoebic
agent when tested on Paramecium caudatum (Chopra et al.
1957). Alcoholic extracts of the rhizomes were active against
the human affecting nematode Ascaris lumbricoides
(Kaleysa Raj 1974) and the rhizome oil was active against
larvae of the root knot nematode Meloidogyne incognita
(Singh et al. 1991). Both forms of asarone showed a dual
effect on the larvae of the nematode Toxocara canis
(Sugimoto et al. 1995). The first was a fast acting temporary
paralytic effect, and the other was a slowly-emerging killing
effect. Anthelmintic and pesticidal activity of a related
species, Acorus gramineus, have been reported to be asso-
ciated with the phenylphenylpropanoids α- and β-asarone
(Perrett and Whitfield 1995) . Both isomers of asarone, par-
ticularly the β form, have therefore been associated with a
wide range of biological activity.
Extracts of Acorus calamus rhizomes have previously
been found to be active in antibacterial, anthelmintic and
anti-amoebic tests (McGaw et al. 2000a). This provided
impetus for a further study attempting to isolate the active
compound(s) using bioassay-guided fractionation, with the
antibacterial agar overlay technique (Slusarenko et al. 1989)
and an anthelmintic assay (Rasoanaivo and Ratsimamanga-
Urverg 1993) as the test bioassays.
Materials and Methods
Plant extraction
Acorus calamus L. plants were collected from a shallow
(approximately 0.3m deep) pond at Silverglen Nursery in
Durban, South Africa in October 1999. A voucher specimen
(McGaw47NU) was deposited at the herbarium of the
University of Natal, Pietermaritzburg. The leaves, roots and
rhizomes were separated and dried at 50°C. The dried, pow-
dered plant parts (4.33g, 13.27g and 17.56g for the leaves,
roots and rhizomes respectively) were extracted separately
with 100ml ethanol. Extraction was performed by sonication
for 30min in a Julabo ultrasound bath, followed by overnight
maceration. The extracts were filtered through Whatman No.
1 filter paper and the procedure was repeated twice with the
same plant material. The filtrates were air-dried and stored
at -20°C.
Antibacterial assays
The antibacterial activity of fractions resulting from each
purification stage was tested using the bioautographic assay
(Slusarenko et al. 1989). An inoculated layer of agar is
poured over a developed TLC plate, and lack of bacterial
growth in certain areas identifies the presence and location
of antibacterial compounds on the TLC plate. TZC (2,3,5-
triphenyltetrazolium chloride) at 0.1% (w/v) was included in
the agar mixture, as an indicator of bacterial growth. The
inhibition of bacterial growth by compounds separated on
the TLC plate is visible as white spots against a deep red
background. The test organism was Staphylococcus aureus.
The Minimal Inhibitory Concentration (MIC) value of the
pure compound was determined against the Gram-positive
Bacillus subtilis (ATCC 6051) and Staphylococcus aureus
(ATCC 12600) and the Gram-negative Escherichia coli
(ATCC 11775) and Klebsiella pneumoniae (ATCC 13883).
The microplate method of Eloff (1998) in 96-well microtiter
plates was used. The pure compound was dissolved in
ethanol and serially diluted twofold with water in microtiter
plate wells. The antibiotic neomycin and extract-free solu-
tions were included as standard and blank controls. An
equal volume (100μl) of bacterial culture (approximately 106
bacteria ml-1) was added to each well. Quantification of the
bacterial inoculum was carried out as previously described
(McGaw et al. 2000a). The microtiter plates were covered
and incubated overnight at 37°C. As an indicator of bacteri-
al growth, 40μl of 0.2mg ml-1 p-iodonitrotetrazolium violet
(INT) solution were added to each well and incubated at
37°C for 30min. The colourless tetrazolium salt is reduced to
a red-coloured product by biological activity, so inhibition of
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bacterial growth is visible as a clear well. MIC values were
recorded as the lowest concentration resulting in complete
inhibition of bacterial growth.
Anthelmintic assay
The anthelmintic activity of extracts, fractions and the pure
compound was determined by incubating the sample (at a
concentration of 1mg ml-1) with Caenorhabditis elegans var.
Bristol (N2) nematodes at 25°C for 2h (Rasoanaivo and
Ratsimamanga-Urverg 1993, modified by McGaw et al.
2000b). Solvent blanks, and levamisole as a standard
anthelmintic drug, were included. The percentage and
movement of live nematodes after incubation with the plant
extracts was recorded and compared to that of the controls.
Isolation
Thin Layer Chromatography (TLC) analysis was used to
compare the chemical composition of the crude ethanol
extracts of Acorus leaves, roots and rhizomes. Bioassay-
guided fractionation was subsequently performed using the
rhizome extract. The ethanolic rhizome extract (1.14g) was
separated by vacuum liquid chromatography (VLC) over sil-
ica gel (Merck 230–400 mesh) using a hexane-ethyl acetate
gradient solvent system of increasing polarity. A column
13cm in length and with an internal diameter of 2cm was
packed with 20g silica. The gradient solvent system was
increased by 5% increments from 100% hexane to 60%
hexane in ethyl acetate, and subsequently by 10% incre-
ments to 100% ethyl acetate. At each concentration, 100ml
solvent was flushed through the column. Bioautography
established that the most active fraction (270mg) was eluted
with 10% ethyl acetate in hexane. This fraction was further
separated by TLC on three silica gel plates (Merck Silica gel
60 F254, 0.25mm thick) using toluene-ethyl acetate (93:7) to
yield 15.6mg of active compound. The purity of this com-
pound, a yellow oil, was confirmed by TLC using various sol-
vent systems.
Identification of isolated compound
High Resolution Mass Spectrometry (MS) using a VG70-
SEQ spectrometer was performed. Nuclear Magnetic
Resonance Spectroscopy (1H NMR and 13C NMR) was car-
ried out to confirm the structure of the compound. A Varian
Unity Inova 500MHz spectrometer was used. The MIC val-
ues of the isolated β-asarone against the four previously
mentioned test bacteria were determined.
Results
The leaf, root and rhizome ethanol extracts of Acorus cala-
mus exhibited antibacterial and anthelmintic activity. The rhi-
zome extract possessed a lower Minimal Inhibitory
Concentration (MIC) than the leaf and root extracts (Table
1), against Bacillus subtilis and Staphylococcus aureus.
Therefore, the rhizome extract was selected to perform
bioassay-guided fractionation for isolation of active com-
pound(s). Additionally, TLC and bioautography displayed
fewer compounds, other than the target active compound, in
the rhizome extract than in the leaf and root extracts. The
activity-directed fractionation of 1.14g of rhizome extract
yielded 15.6mg of oily yellow β-asarone, representing 1.4%
of the extract and 0.09% of the rhizome. The pure com-
pound possessed antibacterial and anthelmintic activity. The
MIC values for the isolated β-asarone against the test bac-
teria are presented in Table 1. The anthelmintic activity of
the crude rhizome extract and isolated β-asarone was very
similar, both resulting in the death of 60–70% of nematodes
after incubation. No other fractions resulting from the frac-
tionation of the rhizome extract exhibited anthelmintic activ-
ity. The structure of β-asarone is presented in Figure 1.
The compound identified as β-asarone was a yellow oil,
C12H16O3 [M]
+ 208.11016. EIMS m/z (rel. int.): 208 [M]+ (100),
193 (47), 177 (3), 165 (27), 162 (12), 150 (6), 134 (3), 103
(4), 91 (11), 77 (7), 69 (3), 51 (2). The 1H NMR spectra in
CDCl3 were δ 1.84 (3H, dd, J = 7.3Hz and 1.8Hz, -CH=CH-
CH3), 3.81, 3.83 and 3.89 (each 3H, s, three OCH3), 5.76
(1H, dq, J = 12Hz and 6.8Hz, H-2’), 6.49 (1H, dq, J = 11.4Hz
and 1.83Hz, H-1’), 6.53 (1H, s, H-3) and 6.84 (1H, s, H-6).
The 13C NMR spectra were recorded in CDCl3, δ 151.5 s (C-
4), 148.5 s (C-2), 142.3 s (C-1), 125.8 d (C-1’), 124.7 d (C-
2’), 118.0 s (C-5), 114.1 d (C-6), 56.6 q, 56.4 q, 56.0 q
(OCH3), 14.6 q (C-3’).
Discussion
The isolated active compound β-asarone has been isolated
previously by others from Acorus calamus growing in
Europe and Asia (Baxter et al. 1960), but has not been eval-
uated for antibacterial and anthelmintic activity before. This
paper demonstrates both the antibacterial and anthelmintic
activity of β-asarone. The anthelmintic activity of the isolated
β-asarone was very similar to that of the crude rhizome
extract. The crude extract and isolated compound were both
tested at the same concentration (1mg ml-1). It was expect-
ed that the isolated β-asarone would display higher
anthelmintic activity than the original extract as it would be
present in a higher concentration. However, this was not the
case, and a possible explanation may be the instability of β-
asarone after isolation, as some breakdown of the com-
pound was visible after TLC analysis. No other anthelmintic
compounds were apparent in the VLC fractions.
The antibacterial activity of the isolated β-asarone was
lower than that of the crude extract. This may again be part-
ly attributed to the lability of the isolated compound. Also,
several other compounds with antibacterial activity in the
VLC fractions of the crude extract were visualised in the
bioautography assay. They made up such a small part of the
overall composition that their identification was not attempt-
ed. β-Asarone appeared to be the major component of the
crude extract (from TLC analysis, and with its yield of 1.4%
of the extract). However, if it were the major antibacterial
compound, it would be expected to have a much lower MIC
value. This was not the case, so other minor compounds
may well have significantly higher antibacterial activity, con-
tributing to a greater proportion of the overall activity even
though they are not present in such high quantities as β-
asarone. Unfortunately, it is not possible to quantify antibac-
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terial activity from a bioautography assay, where the inhibi-
tion spot is by nature a positive/negative response, and does
not reveal detail about the degree of activity of a compound.
The mass spectrometry, 1H and 13C NMR data were con-
sistent with those previously reported for β-asarone (Patra
and Mitra 1981, Mazza, 1985, Nigam et al. 1990, Oprean et
al. 1998). Asarone has been synthesized by two different
methods (Sharma and Dandiya 1969).
The evidence presented indicates that if the Acorus cala-
mus tested in this study is representative of that found in
southern Africa, then the South African Acorus is likely to be
triploid or tetraploid, as these caryotypes of A. calamus are
known to contain β-asarone (Röst and Bos 1979, cited by
Schmidt and Streloke 1994). Also, its origins possibly lie in
Asia or Europe. Of some concern is the evidence implicating
β-asarone in causing duodenal and liver cancer in test ani-
mals. Owing to the possible carcinogenic and toxic effects,
the use of Acorus in digestive medicines has been discon-
tinued in most countries. In South Africa, Acorus calamus is
widely used by Zulu traditional healers to treat a variety of
ailments, including gastrointestinal disorders. The content of
β-asarone substantiates the use of this plant as an
anthelmintic and antibacterial remedy, but owing to the toxi-
city of the active compound, it is recommended that the use
of the plant is restricted to external application for antibac-
terial use, or discontinued altogether.
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